NDC product
Chloraseptic Total Sore Throat and Cough
NDC 67172-016 · Prestige Brands Holdings, Inc.
Key facts
| Product NDC | 67172-016 |
|---|---|
| Proprietary name | Chloraseptic Total Sore Throat and Cough |
| Nonproprietary name | Menthol and Benzocaine and Dextromethorphan Hydrobromide |
| Substances | MENTHOL, BENZOCAINE, DEXTROMETHORPHAN HYDROBROMIDE |
| Dosage form | LOZENGE |
| Route | ORAL |
| Labeler | Prestige Brands Holdings, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M022 |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC] and 2 more |
| Marketing start | Aug 1, 2010 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: